(0.22%) 5 111.30 points
(0.27%) 38 344 points
(0.14%) 15 949 points
(-0.51%) $83.42
(2.34%) $1.968
(0.00%) $2 347.10
(-0.81%) $27.31
(2.35%) $943.75
(0.06%) $0.935
(0.03%) $11.03
(-0.18%) $0.799
(1.93%) $93.64
@ $29.87
发出时间: 15 Feb 2024 @ 04:49
回报率: 59.36%
上一信号: Feb 14 - 22:30
上一信号:
回报率: -0.71 %
Live Chart Being Loaded With Signals
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye...
Stats | |
---|---|
今日成交量 | 6 154.00 |
平均成交量 | 719 372 |
市值 | 2.34B |
EPS | $0 ( 2024-02-26 ) |
下一个收益日期 | ( $0.0400 ) 2024-06-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 110.70 |
ATR14 | $0.0550 (0.12%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-14 | Weisner Aimee S | Buy | 1 750 | Common Stock |
2024-03-12 | Frinzi Thomas G | Buy | 74 389 | Restricted Stock Units |
2024-03-12 | Frinzi Thomas G | Buy | 66 627 | Common Stock Options |
2024-03-12 | Foust Warren | Buy | 24 525 | Restricted Stock Units |
2024-03-12 | Foust Warren | Buy | 21 966 | Common Stock Options |
INSIDER POWER |
---|
98.83 |
Last 95 transactions |
Buy: 2 389 846 | Sell: 13 779 |
音量 相关性
STAAR Surgical Co 相关性 - 货币/商品
STAAR Surgical Co 财务报表
Annual | 2023 |
营收: | $322.42M |
毛利润: | $252.65M (78.36 %) |
EPS: | $0.440 |
FY | 2023 |
营收: | $322.42M |
毛利润: | $252.65M (78.36 %) |
EPS: | $0.440 |
FY | 2022 |
营收: | $284.39M |
毛利润: | $223.38M (78.55 %) |
EPS: | $0.830 |
FY | 2021 |
营收: | $230.47M |
毛利润: | $178.64M (77.51 %) |
EPS: | $0.520 |
Financial Reports:
No articles found.
STAAR Surgical Co
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。